KK
PCVX icon

KLP Kapitalforvaltning’s Vaxcyte PCVX Stock Holding History

KLP Kapitalforvaltning’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
27,700
+1,800
+7% +$97.8K 0.01% 885
2026
Q1 		$1.51M Buy
25,900
+900
+4% +$48.9K 0.01% 829
2025
Q4 		$1.15M Buy
25,000
+400
+2% +$17.9K ﹤0.01% 964
2025
Q3 		$886K Hold
24,600
– – ﹤0.01% 1100
2025
Q2 		$800K Buy
24,600
+1,600
+7% +$52.5K ﹤0.01% 1106
2025
Q1 		$868K Buy
23,000
+500
+2% +$40K ﹤0.01% 1006
2024
Q4 		$1.84M Buy
+22,500
New +$2.23M 0.01% 693

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

KLP Kapitalforvaltning's PCVX Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Vaxcyte (PCVX) stake by 6.9% in Q2 2026, buying an estimated $97.8K and bringing the position to 27,700 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #885.

KLP Kapitalforvaltning first reported a position in PCVX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.84M in Q4 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • KLP Kapitalforvaltning held 27,700 shares of Vaxcyte worth $1.61M as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,800 Vaxcyte shares in Q2 2026, an estimated $97.8K.
  • Vaxcyte made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #885 holding.
  • KLP Kapitalforvaltning first reported a position in Vaxcyte in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Vaxcyte position peaked at $1.84M in Q4 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.